UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 183

Sortiert nach

Sex differences in arterial hypertension

European heart journal, 2022-12, Vol.43 (46), p.4777-4788

2022

Link zum Volltext

Verfügbarkeit prüfen

Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

Europace (London, England), 2017-06, Vol.19 (6), p.891-911

2017

Link zum Volltext

Verfügbarkeit prüfen

Hypertension-mediated organ damage involving multiple sites is an independent risk factor for cardiovascular events

European heart journal open, 2023-09, Vol.3 (5), p.oead102-oead102

2023

Link zum Volltext

Verfügbarkeit prüfen

Fatty acid desaturase genetic variations and dietary omega-3 fatty acid intake associate with arterial stiffness

European heart journal open, 2022-03, Vol.2 (2), p.oeac016-oeac016

2022

Link zum Volltext

Verfügbarkeit prüfen

ESC Council on hypertension position document on the management of hypertensive emergencies

European heart journal. Cardiovascular pharmacotherapy, 2019, Vol.5 (1), p.37-46

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of baseline blood pressure on adverse outcomes in Japanese patients with non-valvular atrial fibrillation: the J-RISK AF

European heart journal open, 2022-11, Vol.2 (6), p.oeac081-oeac081

2022

Link zum Volltext

Verfügbarkeit prüfen

Blood pressure, heart rate, or the Rate Pressure Product: what is the best predictor of clinical outcome?

European heart journal open, 2022-09, Vol.2 (5), p.oeac063-oeac063

2022

Link zum Volltext

Verfügbarkeit prüfen

Survey on arterial hypertension management: a report from the ESC Council for Cardiology Practice and the ESC Council on Hypertension

European heart journal open, 2021-09, Vol.1 (2), p.oeab013-oeab013

2021

Link zum Volltext

Verfügbarkeit prüfen

Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study

Journal of hypertension, 2016-11, Vol.34 (11), p.2187-2198

2016

Link zum Volltext

Verfügbarkeit prüfen

13.1 THE EFFECTS OF ALPHA 1-ADRENOCEPTOR-BLOCKADE AND ANGIOTENSIN CONVERTING ENZYME-INHIBITION ON INDICES OF AORTIC STIFFNESS MEASURED BY AN OSCILLOMETRIC SINGLE CUFF METHOD IN HYPERTENSION: THE DOXAZOSIN RAMIPRIL STUDY

Artery research, 2016-11, Vol.16 (C), p.79

2016

Link zum Volltext

Verfügbarkeit prüfen

P3.17 The Effects of Alpha 1-Adrenoceptor-Blockade by Doxazosin and Angiotensin Converting Enzyme-Inhibition by Ramipril On Central and Brachial Blood Pressure and Vascular Reactivity in Mild-To-Moderate Hypertension: The Doxazosin Ramipril Study

Artery research, 2015, Vol.12 (1), p.14-14

2015

Link zum Volltext

Verfügbarkeit prüfen

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

European heart journal, 2022-11, Vol.43 (41), p.4229-4361

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial

European heart journal, 2009-03, Vol.30 (5), p.540-548

2009

Link zum Volltext

Verfügbarkeit prüfen

2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

European heart journal, 2021-09, Vol.42 (35), p.3427-3520

2021

Link zum Volltext

Verfügbarkeit prüfen

Hypertension, RAAS blockade and risk in COVID-19 patients

Läkartidningen, 2020-06, Vol.117

2020

Link zum Volltext

Verfügbarkeit prüfen

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

European heart journal, 2013-07, Vol.34 (28), p.2159-2219

2013

Link zum Volltext

Verfügbarkeit prüfen

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

European heart journal cardiovascular imaging, 2022-09, Vol.23 (10), p.e333-e465

2022

Link zum Volltext

Verfügbarkeit prüfen

Resistant hypertension: new perspectives for difficult-to-treat group

Läkartidningen, 2013-01, Vol.110 (3), p.76-76

Kahan, Thomas

2013

Link zum Volltext

Verfügbarkeit prüfen

Single nucleotide polymorphisms predict the change in left ventricular mass in response to antihypertensive treatment

Journal of hypertension, 2004-12, Vol.22 (12), p.2321-2328

2004

Link zum Volltext

Verfügbarkeit prüfen

Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease

Atherosclerosis, 2021-12, Vol.338, p.55-63

2021

Link zum Volltext

Verfügbarkeit prüfen

ECG monitoring in in-hospital cardiac arrest (IHCA)

Resuscitation, 2019-09, Vol.142, p.e13-e13

2019

Link zum Volltext

Verfügbarkeit prüfen

Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of Hypertension

Journal of hypertension, 2017-09, Vol.35 (9), p.1727-1741

2017

Link zum Volltext

Verfügbarkeit prüfen

Reply

Journal of hypertension, 2018-08, Vol.36 (8), p.1770-1771

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 183

Suche als RSS-Feed

Aktive Filter

SpracheFranzösisch

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(161)
Mit Volltextzugriff
(171)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Medicin Och Hälsovetenskap
(46)
Humans
(45)
Female
(25)
Hypertension
(24)
Male
(24)
Biological And Medical Sciences
(22)
Blood Pressure
(20)
Hypertension - Drug Therapy
(16)
Middle Aged
(15)
Life Sciences
(13)
Medical Sciences
(13)
Antihypertensive Agents - Therapeutic Use
(11)
Medicin
(11)
Medicine
(11)
Risk Factors
(11)
Social Sciences
(11)
Treatment Outcome
(11)
Adult
(10)
Atenolol - Therapeutic Use
(10)
Left Ventricular Hypertrophy
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sex differences in arterial hypertension

Hypertension-mediated organ damage involving multiple sites is an independent risk factor for cardiovascular events

Fatty acid desaturase genetic variations and dietary omega-3 fatty acid intake associate with arterial stiffness

ESC Council on hypertension position document on the management of hypertensive emergencies

Impact of baseline blood pressure on adverse outcomes in Japanese patients with non-valvular atrial fibrillation: the J-RISK AF

Blood pressure, heart rate, or the Rate Pressure Product: what is the best predictor of clinical outcome?

Survey on arterial hypertension management: a report from the ESC Council for Cardiology Practice and the ESC Council on Hypertension

Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study

13.1 THE EFFECTS OF ALPHA 1-ADRENOCEPTOR-BLOCKADE AND ANGIOTENSIN CONVERTING ENZYME-INHIBITION ON INDICES OF AORTIC STIFFNESS MEASURED BY AN OSCILLOMETRIC SINGLE CUFF METHOD IN HYPERTENSION: THE DOXAZOSIN RAMIPRIL STUDY

2018 Practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension

P3.17 The Effects of Alpha 1-Adrenoceptor-Blockade by Doxazosin and Angiotensin Converting Enzyme-Inhibition by Ramipril On Central and Brachial Blood Pressure and Vascular Reactivity in Mild-To-Moderate Hypertension: The Doxazosin Ramipril Study

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: ESC/ESH Task Force for the Management of Arterial Hypertension

Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial

2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

Hypertension, RAAS blockade and risk in COVID-19 patients

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

Resistant hypertension: new perspectives for difficult-to-treat group

Single nucleotide polymorphisms predict the change in left ventricular mass in response to antihypertensive treatment

Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease

ECG monitoring in in-hospital cardiac arrest (IHCA)

Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of Hypertension

Reply

Aktive Filter

Suchergebnisse filtern